Cargando…
Clinical benefit of high dose IL-2 (HD IL-2) therapy: evidence for improved overall survival in patients with stable disease
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2013
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3990294/ http://dx.doi.org/10.1186/2051-1426-1-S1-P105 |
| _version_ | 1782312256530284544 |
|---|---|
| author | Hughes, Tasha Iodice, Gail Basu, Sanjib Bines, Steven Kaufman, Howard |
| author_facet | Hughes, Tasha Iodice, Gail Basu, Sanjib Bines, Steven Kaufman, Howard |
| author_sort | Hughes, Tasha |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-3990294 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2013 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-39902942014-05-01 Clinical benefit of high dose IL-2 (HD IL-2) therapy: evidence for improved overall survival in patients with stable disease Hughes, Tasha Iodice, Gail Basu, Sanjib Bines, Steven Kaufman, Howard J Immunother Cancer Poster Presentation BioMed Central 2013-11-07 /pmc/articles/PMC3990294/ http://dx.doi.org/10.1186/2051-1426-1-S1-P105 Text en Copyright © 2013 Hughes et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Poster Presentation Hughes, Tasha Iodice, Gail Basu, Sanjib Bines, Steven Kaufman, Howard Clinical benefit of high dose IL-2 (HD IL-2) therapy: evidence for improved overall survival in patients with stable disease |
| title | Clinical benefit of high dose IL-2 (HD IL-2) therapy: evidence for improved overall survival in patients with stable disease |
| title_full | Clinical benefit of high dose IL-2 (HD IL-2) therapy: evidence for improved overall survival in patients with stable disease |
| title_fullStr | Clinical benefit of high dose IL-2 (HD IL-2) therapy: evidence for improved overall survival in patients with stable disease |
| title_full_unstemmed | Clinical benefit of high dose IL-2 (HD IL-2) therapy: evidence for improved overall survival in patients with stable disease |
| title_short | Clinical benefit of high dose IL-2 (HD IL-2) therapy: evidence for improved overall survival in patients with stable disease |
| title_sort | clinical benefit of high dose il-2 (hd il-2) therapy: evidence for improved overall survival in patients with stable disease |
| topic | Poster Presentation |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3990294/ http://dx.doi.org/10.1186/2051-1426-1-S1-P105 |
| work_keys_str_mv | AT hughestasha clinicalbenefitofhighdoseil2hdil2therapyevidenceforimprovedoverallsurvivalinpatientswithstabledisease AT iodicegail clinicalbenefitofhighdoseil2hdil2therapyevidenceforimprovedoverallsurvivalinpatientswithstabledisease AT basusanjib clinicalbenefitofhighdoseil2hdil2therapyevidenceforimprovedoverallsurvivalinpatientswithstabledisease AT binessteven clinicalbenefitofhighdoseil2hdil2therapyevidenceforimprovedoverallsurvivalinpatientswithstabledisease AT kaufmanhoward clinicalbenefitofhighdoseil2hdil2therapyevidenceforimprovedoverallsurvivalinpatientswithstabledisease |